IceCure Medical (ICCM)

• Market cap: $66.2M
• 1 day: -0.88%
• 5 days: -0.88%
• 1 month: -25.66%
• 3 months: -7.38%
• 6 months: 113.61%
• Year to date: -8.13%
• 1 year: -12.40%
• 5 years: -89.63%
• 10 years: -89.63%
• Sector: Healthcare
• Industry: Medical Devices

About: Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Employees: 66

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

43% more capital invested

Capital invested by funds: $118K [Q3] → $169K (+$50.8K) [Q4]

0.11% less ownership

Funds ownership: 0.39% [Q3] → 0.28% (-0.11%) [Q4]

13% less funds holding

Funds holding: 15 [Q3] → 13 (-2) [Q4]

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $2.50 121% upside
• Avg. target: $2.50 121% upside
• High target: $2.50 121% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Yi Chen 27% 1-year accuracy 46 / 173 met price target

121% upside $2.50

Buy Reiterated

28 Mar 2025